Showing results (11-20 of 468) with videos related to
Sort By:
Pageof 47
Retrovirology|December 13, 2012
SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferonsCorine St Gelais, Suresh de Silva, Sarah M Amie, et al.Plos One|January 4, 2017
Substrates and Inhibitors of SAMHD1Joseph A Hollenbaugh, Jadd Shelton, Sijia Tao, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysisJoseph A Hollenbaugh, Joyce Reome, Mark Dobrzanski, et al.Addiction Biology|November 29, 2023
Fentanyl-induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 monthsJeffrey D Benner, Steven M Cohen, Joseph A Hollenbaugh, et al.Virology|May 17, 2016
SAMHD1 controls cell cycle status, apoptosis and HIV-1 infection in monocytic THP-1 cellsSerena Bonifati, Michele B Daly, Corine St Gelais, et al.Plos Pathogens|July 5, 2013
Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cellsJoseph A Hollenbaugh, Peter Gee, Jonathon Baker, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responsesMark J Dobrzanski, Joyce B Reome, Joseph A Hollenbaugh, et al.Clinical Immunology (Orlando, Fla.)|January 3, 2006
The immune system provides a strong response to even a low exposure to virusTimothy J Powell, David W Dwyer, Tammy Morgan, et al.Chemical Reviews|December 15, 2016
Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base AnalogsJadd Shelton, Xiao Lu, Joseph A Hollenbaugh, et al.Cancer Research|January 20, 2004
Effector cell-derived lymphotoxin alpha and Fas ligand, but not perforin, promote Tc1 and Tc2 effector cell-mediated tumor therapy in established pulmonary metastasesMark J Dobrzanski, Joyce B Reome, Joseph A Hollenbaugh, et al.Pageof 47